RecallDepth
Class II Ongoing

Wegovy (semaglutide) injection, 2.4 mg/0.75 mL, 4 Single-Dose Prefilled Pens per Carton, For Subcutaneous Use Only, Rx Only, Single-Dose Only, Novo Nordisk Inc., Plainsboro, NJ 08536, Manufactured by: Novo Nordisk A/S, DK-2880, Bagsvaerd, Denmark, NDC 0169-4524-14.

Company
Cardinal Health Inc.
Recall Initiated
April 9, 2025
Posted
May 7, 2025
Recall Number
D-0393-2025
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
48 Cartons
Firm Location
Dublin, OH, United States

Reason for Recall

Temperature abuse: Wegovy product was potentially exposed to temperatures outside of the products labeled storage conditions due to a shipping error involving a Cardinal Health distribution center. More specifically, product was removed from refrigerated storage for an extended period of time and inappropriately released.

Distribution

NC, SC, VA

Lot / Code Info

Lot PZFDE06, Exp 08/31/2025

More recalls by Cardinal Health Inc.

View all recalls by this company →

Other recent Class II Drug recalls